Shares of several companies including Bharat Electronics, Piramal Pharma, Hindustan Aeronautics, and Aditya Birla Real Estate ...

said Ajay Piramal. For making a company successful, Nandini, who joined the family business in 2006 and took charge as the pharma business's chairperson in 2022, believes it's important to have ...

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...

Piramal Critical Care and BrePco Biopharma received UK approval for Neoatricon, a paediatric Dopamine Hydrochloride solution.

The analysts expressed confidence in Piramal Pharma’s leadership in key products within the CHG segment, which is supported by the company’s backward integration strategy. They anticipate a ...

Piramal had acquired stakes in various Shriram companies more than a decade ago, after selling its pharmaceuticals business to Abbott Laboratories in 2010. In recent years, Piramal has sold some ...

Kotak’s analysts highlighted Piramal Pharma’s transformation into a significant player in the Contract Research and Development Manufacturing Organization (CRDMO) sector, noting a decade of strategic ...

Piramal Pharma Limited stated that Piramal Critical Care (PCC) and Ireland-based BrePco Biopharma Ltd (BPCO) have received approval from UK Medicines and Healthcare Products Regulatory Agency ...

Nandini Piramal says the CDMO business, which contributed 58% of revenues in FY24, aspires to grow as a $1.2 billion business with a 25% EBITDA margin by 2030 ...

In today's session, Piramal Pharma experienced a notable surge ... This broad representation across various market segments underscores the company's significance within the Indian equity landscape.

Piramal Enterprises said it has solid grounds to challenge the "unjustified" demand. The company sold its pharmaceutical business and other related units to Piramal Pharma for 44.87 billion rupees in ...

Mumbai: Abbott India has announced the appointment of Devesh Choudhari as Director - Finance effective April 1, 2025. He will ...